Change management at a Hungarian market leader pharmaceutical corporation in light of the transition from the socialist political structure into capitalism
Elmentve itt :
| Szerző: | |
|---|---|
| További közreműködők: | |
| Dokumentumtípus: | Diplomadolgozat |
| Kulcsszavak: | pharmaceutical corporation change management |
| Online Access: | http://dolgozattar.uni-bge.hu/20331 |
MARC
| LEADER | 00000nta a2200000 i 4500 | ||
|---|---|---|---|
| 001 | dolg20331 | ||
| 005 | 20190905155803.0 | ||
| 008 | 190503suuuu hu om 000 eng d | ||
| 040 | |a BGE Dolgozattár Repozitórium |b hun | ||
| 041 | |a en | ||
| 100 | 1 | |a Kruppa Gergely | |
| 245 | 1 | 0 | |a Change management at a Hungarian market leader pharmaceutical corporation in light of the transition from the socialist political structure into capitalism |c Kruppa Gergely |h [elektronikus dokumentum] |
| 246 | 1 | 1 | |a Változás menedzsment egy gyógyszerkereskedelmi vállalat példáján keresztül |
| 246 | 1 | 1 | |a Change management at a Hungarian market leader pharmaceutical corporation |
| 520 | 3 | |a 1. Acknowledgments 3 2. Introduction 4 2.1 Research questions and method of investigation 4 2.2 Historical background of “The Corporation” in previous regime 6 2.3 Understanding the theoretical background of change management 8 2.4 Background of “the Corporation” and research and development in medicine trade 12 2.5 Organizational dilemma, principles according to environment 13 2.6 OTC marketing trends attribute towards customer 14 3. Market Research 17 3.1 How has “The Corporation” structure adopted itself? 17 3.2 How does the - in some cases strict - regulation impacts the pharmaceutical companies? 25 3.3 Illegal medicine trade issue in Hungary 30 4. Analysis of change management in the organization 31 4.1 Kotters 8 steps of change 31 4.2 Primary Research PESTLE focus on macro economical aspects 34 4.3 Porter Five Force which focuses on microeconomic environment 36 5. Current and future aspects of the Pharmaceutical Industry 38 5.1 Opportunities in medicine trade fundamental analysis of a competitor 38 5.2 Future aspects of international medicine market 39 6. Conclusion 42 6.1 Main Findings for “The Corporation” 43 7.Sources 44 | |
| 695 | |a pharmaceutical corporation | ||
| 695 | |a change management | ||
| 700 | 1 | |a Kozák Dr. Tamás József |e ths | |
| 856 | 4 | 0 | |u http://dolgozattar.uni-bge.hu/20331/1/Thesis_Kruppa_Gergely_Pharmaceutical_corporation_24th-April-2019.pdf |z Dokumentum-elérés |